We elucidated the mutual function of HIF1A-AS2 and miR-30a-5p in renal carcinomas, which could provide a novel biomarker and therapeutic target for the diagnosis and treatment of renal carcinomas. The gene discussed is HIF1A; the disease is renal carcinoma.